hers vs noom for glp 1 The Best Microdose GLP-1 Programs Online in 2026 Noom GLP-1 Review 2026: Great

A 2025 analysis found that GLP-1 agonists given for diabetes were associated with a reduced risk of substance use among hundreds of thousands of United States Veterans and a 2024 examination of over 500k patients 4 Qeadan, F., McCunn, A., & Tingey, B

10.3389/fnmol.2021.697440 45 MarsoS

See related: Along with rapid weight loss, patients see other benefits and risks of GLP-1 drugs Health experts also caution that people taking GLP-1 medications should work closely with a medical provider

Patients in Stamford, Greenwich, Fairfield County, and throughout Connecticut can call 203-348-8805 to discuss whether GLP-1 therapy, semaglutide, tirzepatide, or a medically supervised weight loss adjustment may be appropriate

The drug also poses a significant risk of birth defects and must not be used during pregnancy, making it unsuitable for women who are or may become pregnant